Stock REMUS REMUS PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Remus Pharmaceuticals Limited

Equities

REMUS

INE0O5T01011

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:40:30 2024-07-16 EDT 		5-day change 1st Jan Change
1,950 INR -1.91% Intraday chart for Remus Pharmaceuticals Limited -6.22% +1.91%
05-31 790,000 Equity Shares of Remus Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 31-MAY-2024. CI
05-16 Remus Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Income Statement Evolution (Annual data)

Fiscal Period: March 2020 2021 2022 2023
Net sales 1 124.2 188.1 247.2 451.3
EBITDA 1 10.42 13.38 43.16 111.4
EBIT 1 9.357 11.63 41.62 106.7
Operating Margin 7.53% 6.18% 16.84% 23.64%
Earnings before Tax (EBT) 1 10.94 13.58 45.49 114.1
Net income 1 8.116 10.26 33.86 85.03
Net margin 6.54% 5.45% 13.7% 18.84%
EPS 2 2.029 2.564 8.464 20.82
Free Cash Flow - 24.7 42.62 7.453
FCF margin - 13.13% 17.24% 1.65%
FCF Conversion (EBITDA) - 184.59% 98.74% 6.69%
FCF Conversion (Net income) - 240.76% 125.89% 8.77%
Dividend per Share - - - 0.5000
Announcement Date 23-03-13 23-03-13 23-03-13 23-05-29
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2020 2021 2022 2023
Net Debt 1 - - - 49
Net Cash position 1 8.39 5.52 9.57 -
Leverage (Debt/EBITDA) - - - 0.4404 x
Free Cash Flow - 24.7 42.6 7.45
ROE (net income / shareholders' equity) - 40.5% 71.4% 66.1%
ROA (Net income/ Total Assets) - 8.89% 19.3% 26.4%
Assets 1 - 115.4 175.5 322
Book Value Per Share 2 5.050 7.620 14.80 44.10
Cash Flow per Share 2 3.000 2.080 2.650 7.000
Capex 1 5.59 0.66 0.71 27.3
Capex / Sales 4.5% 0.35% 0.29% 6.05%
Announcement Date 23-03-13 23-03-13 23-03-13 23-05-29
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
REMUS PHARMACEUTICALS LIMITED Stock Remus Pharmaceuticals Limited
+1.91% 137M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+57.45% 848B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.64% 627B
JOHNSON & JOHNSON Stock Johnson & Johnson
-0.76% 363B
MERCK & CO., INC. Stock Merck & Co., Inc.
+14.96% 318B
ABBVIE INC. Stock AbbVie Inc.
+12.09% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.49% 243B
NOVARTIS AG Stock Novartis AG
+16.74% 225B
AMGEN INC. Stock Amgen Inc.
+15.82% 179B
PFIZER, INC. Stock Pfizer, Inc.
+3.36% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. REMUS Stock
  4. Financials Remus Pharmaceuticals Limited